These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 3996575
1. [Effect of delagil on the blood coagulation system and the interrelation with heparin]. Ovchinnikova LK, Pomortseva IV. Farmakol Toksikol; 1985; 48(2):77-81. PubMed ID: 3996575 [Abstract] [Full Text] [Related]
2. [Influence of bigumal on the blood coagulation system and on the anticoagulant effect of heparin]. kremneva VF, Ushkalova EA, Shcheglova NV. Farmakol Toksikol; 1986; 49(6):43-5. PubMed ID: 3817142 [Abstract] [Full Text] [Related]
3. [The influence of the Soviet antimalarial preparation dabequin on the hemostatic system and on the anticoagulant effect of heparin]. Pomortseva IV, Ovchinnikova LK, Shcheglova NV. Farmakol Toksikol; 1990; 53(1):59-62. PubMed ID: 2328805 [Abstract] [Full Text] [Related]
4. [Influence of nonachlazin, riboxin and isoptin on the blood coagulation system and the anticoagulant effect of heparin]. Shevchenko LV, Ovchinnikova LK, Zolotukhin SI. Farmakol Toksikol; 1980; 43(4):389-95. PubMed ID: 7439373 [Abstract] [Full Text] [Related]
8. [Comparative study of the properties of dicoumarin and its compounds with heparin]. Kudriashov BA, Liapina LA, Zvereva EG. Vopr Med Khim; 1985; 31(2):79-83. PubMed ID: 2408377 [Abstract] [Full Text] [Related]
9. [Use of dibunol and delagil in the treatment of acute pancreatitis]. Buianov VM, Stupin IV, Zheltikov AN, Sherstnev MP. Vestn Khir Im I I Grek; 1988 Dec; 141(12):28-32. PubMed ID: 3250058 [Abstract] [Full Text] [Related]
10. [The blood anticoagulant system in rats perorally administered a heparin-acetylsalicylic acid complex]. Kudriashov BA, Liapina LA, Pastorova VE, Kondashevskaia MV. Izv Akad Nauk SSSR Biol; 1991 Dec; (4):625-30. PubMed ID: 1787232 [Abstract] [Full Text] [Related]
11. [Antithrombin III activity in relation to multiple administration of various doses of heparin to normal animals]. Kudriashov BA, Pastorova VE, Liapina LA. Vopr Med Khim; 1985 Dec; 31(3):37-41. PubMed ID: 4024529 [Abstract] [Full Text] [Related]
14. Fucosylated chondroitin sulfate as a new oral antithrombotic agent. Fonseca RJ, Mourão PA. Thromb Haemost; 2006 Dec; 96(6):822-9. PubMed ID: 17139379 [Abstract] [Full Text] [Related]
15. A new route of heparin administration--the lung. Kavanagh LW, Jaques LB. Arzneimittelforschung; 1976 Dec; 26(3):389-92. PubMed ID: 989334 [Abstract] [Full Text] [Related]
16. Reversal of protamine of the prolonged response to intrapulmonary heparin. Wright CJ, Mahadoo J, Jaques LB. Can J Surg; 1981 Mar; 24(2):130-2. PubMed ID: 7225967 [Abstract] [Full Text] [Related]
17. The influence of epsilon-aminocaproic acid derivatives on the anticoagulant activity of heparin. Midura-Nowaczek K, Bruzgo I, Worowski K, Roszkowska-Jakimiec W. Rocz Akad Med Bialymst; 1998 Mar; 43():228-31. PubMed ID: 9972059 [Abstract] [Full Text] [Related]
18. Activated coagulation time test: a convenient monitor of heparinization for dogs used in cardiovascular research. Wilkerson RD, Conran PB, Greene SL. Lab Anim Sci; 1984 Feb; 34(1):62-5. PubMed ID: 6716959 [Abstract] [Full Text] [Related]
19. Activated coagulation time in monitoring heparinized dogs. Green RA. Am J Vet Res; 1980 Nov; 41(11):1793-7. PubMed ID: 7212408 [Abstract] [Full Text] [Related]